secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001104659-21-132583
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corvus enters $40M ATM equity offering with Jefferies LLC
---------------------------------------------------------

- Sales agreement for up to $40M in common stock, Jefferies as sales agent.
- Jefferies receives up to 3% commission on gross proceeds from sales.
- Sales may occur through Nasdaq, block trades, or privately negotiated transactions.
- Company may suspend or terminate the agreement at any time; no obligation to sell shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/0001104659-21-132583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/tm2131487d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-132583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer